Mar 13 |
ADC Therapeutics SA (ADCT) Reports Mixed 2023 Financial Results Amid Strategic Reset
|
Mar 13 |
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 13 |
ADC Therapeutics Non-GAAP EPS of -$0.97, revenue of $16.79M beats by $1.53M
|
Mar 13 |
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
|
Mar 13 |
Earnings Scheduled For March 13, 2024
|
Mar 12 |
ADC Therapeutics Q4 Earnings Preview
|
Mar 11 |
Adobe (ADBE) to Report Q1 Earnings: What's in the Offing?
|
Mar 6 |
Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates
|
Mar 6 |
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
|
Mar 6 |
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024
|